全文获取类型
收费全文 | 2196篇 |
免费 | 133篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 172篇 |
妇产科学 | 30篇 |
基础医学 | 240篇 |
口腔科学 | 66篇 |
临床医学 | 285篇 |
内科学 | 514篇 |
皮肤病学 | 73篇 |
神经病学 | 60篇 |
特种医学 | 405篇 |
外科学 | 95篇 |
综合类 | 54篇 |
预防医学 | 106篇 |
眼科学 | 26篇 |
药学 | 127篇 |
2篇 | |
中国医学 | 9篇 |
肿瘤学 | 138篇 |
出版年
2023年 | 4篇 |
2022年 | 6篇 |
2021年 | 13篇 |
2020年 | 16篇 |
2019年 | 20篇 |
2018年 | 35篇 |
2017年 | 27篇 |
2016年 | 29篇 |
2015年 | 43篇 |
2014年 | 65篇 |
2013年 | 76篇 |
2012年 | 47篇 |
2011年 | 45篇 |
2010年 | 100篇 |
2009年 | 91篇 |
2008年 | 60篇 |
2007年 | 101篇 |
2006年 | 68篇 |
2005年 | 68篇 |
2004年 | 31篇 |
2003年 | 24篇 |
2002年 | 34篇 |
2001年 | 47篇 |
2000年 | 37篇 |
1999年 | 33篇 |
1998年 | 132篇 |
1997年 | 157篇 |
1996年 | 132篇 |
1995年 | 109篇 |
1994年 | 116篇 |
1993年 | 102篇 |
1992年 | 29篇 |
1991年 | 35篇 |
1990年 | 39篇 |
1989年 | 54篇 |
1988年 | 46篇 |
1987年 | 45篇 |
1986年 | 50篇 |
1985年 | 46篇 |
1984年 | 26篇 |
1983年 | 15篇 |
1982年 | 24篇 |
1981年 | 29篇 |
1980年 | 25篇 |
1979年 | 4篇 |
1978年 | 8篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1975年 | 14篇 |
1966年 | 1篇 |
排序方式: 共有2404条查询结果,搜索用时 15 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
3.
Systemic anticancer therapy for hepatocellular carcinoma (HCC) is limited by intrinsic drug resistance and accompanying liver
dysfunction. However, recent advances in molecular targeted therapy (MTT) have shed light on the treatment of advanced HCC.
A recent randomized, placebo-controlled trial demonstrated that sorafenib, a multi-target tyrosine kinase inhibitor, prolonged
overall survival and time-to-progression in patients with advanced HCC. This breakthrough highlights the potential of MTT
targeting hepatocarcinogenic pathways, such as the Raf/MAPK/ERK pathway, angiogenic pathways and the EGFR signaling pathway.
This review discusses the current status and the potential of developing novel MTTs for advanced HCC. 相似文献
4.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
5.
6.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
7.
应用半乳糖-半乳糖胺检测法对118份直肠粘液标本作了检查。在30例大肠癌病人中其阳性率达90%,在65例肠粘膜正常人中,其阴性率达92.3%;另外20例大肠息肉病人中,其阳性率为15%,3例溃疡性结肠炎病人中阳性率为66.7%。结果表明:该法有较高的敏感性(90%)和特异性(92.3%),方法简便,结果易重复,在大肠癌普查中具有较大的应用潜力;在大肠息肉和溃疡结肠性炎中也有一定的阳性率,提示该法可用于某些大肠癌癌前状态恶变的监测。 相似文献
8.
9.
10.